- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 409/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 409/06
Total number of patents in this class: 1241
10-year publication summary
|
105
|
88
|
83
|
80
|
96
|
82
|
61
|
59
|
66
|
9
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2600 |
49 |
| Janssen Pharmaceutica N.V. | 3839 |
30 |
| Takeda Pharmaceutical Company Limited | 2961 |
23 |
| Nihon Nohyaku Co., Ltd. | 313 |
22 |
| POLA Pharma Inc. | 77 |
20 |
| Boehringer Ingelheim International GmbH | 4629 |
15 |
| Shionogi & Co., Ltd. | 914 |
15 |
| Astellas Pharma Inc. | 1145 |
14 |
| FUJIFILM Corporation | 27102 |
13 |
| Cayman Chemical Company, Incorporated | 72 |
13 |
| F. Hoffmann-La Roche AG | 7958 |
12 |
| Merck Patent GmbH | 5909 |
12 |
| Centre National de La Recherche Scientifique | 9632 |
12 |
| Galderma Research & Development | 440 |
12 |
| Bristol-myers Squibb Company | 5080 |
10 |
| AstraZeneca AB | 3042 |
10 |
| Syngenta Participations AG | 4970 |
10 |
| Alectos Therapeutics Inc. | 49 |
10 |
| Biosplice Therapeutics, Inc. | 166 |
10 |
| Bayer Pharma AG | 1096 |
9 |
| Other owners | 920 |